Likely Cause and Evaluation Approach
This 80-year-old man with pancytopenia (Hb 4.7, platelets 90k, WBC 3600) most likely has myelodysplastic syndrome (MDS), but you must first exclude reversible causes including vitamin B12 deficiency, folate deficiency, copper deficiency, and medication effects before proceeding to bone marrow biopsy.
Initial Laboratory Workup
Start with these specific tests to rule out treatable causes that can mimic MDS:
- Vitamin B12 and folate levels - B12 deficiency can present identically to MDS with severe pancytopenia and bone marrow dysplasia 1
- Serum copper and ceruloplasmin - Copper deficiency mimics both B12 deficiency and MDS with anemia, leukopenia, and thrombocytopenia 2
- Iron studies (serum iron, TIBC, ferritin, transferrin saturation) - Functional iron deficiency is common in elderly anemia 3
- C-reactive protein (CRP) - Chronic inflammation is present in 62% of anemic elderly patients 3
- Reticulocyte count - Helps distinguish production vs. destruction
- Peripheral blood smear - Look for macrocytosis, hypersegmented neutrophils (B12/folate), or dysplastic features
- Comprehensive medication review - Many drugs cause cytopenias in elderly patients 4
Critical Diagnostic Pitfall
Do NOT proceed directly to bone marrow biopsy without checking B12, folate, and copper first 1. Performing bone marrow biopsy prematurely can lead to misdiagnosis of MDS when the patient actually has a reversible nutritional deficiency. The bone marrow will show dysplastic changes in both conditions, but the treatment and prognosis are completely different 1.
When to Proceed to Bone Marrow Biopsy
Perform bone marrow aspiration and biopsy with cytogenetics if:
- Nutritional deficiencies are excluded or corrected without improvement
- Peripheral smear shows circulating blasts
- Progressive worsening of cytopenias
- No clear reversible cause identified
The bone marrow evaluation should include 5:
- Morphology assessment for dysplasia
- Blast percentage
- Cytogenetic analysis (karyotype)
- Consider FISH if karyotype unsuccessful
Most Likely Diagnosis: MDS
Given the patient's age and presentation, MDS remains the leading diagnosis after exclusions 3. In elderly patients with unexplained pancytopenia:
- Thrombocytopenia occurs in 5.4% of anemic elderly 3
- Leukopenia in 8.26% 3
- Macrocytic changes in 18.4% 3
- A substantial proportion have undiagnosed MDS 3
Risk Stratification After MDS Diagnosis
Once MDS is confirmed, use IPSS or IPSS-R scoring to guide treatment 5:
Lower-risk MDS (IPSS Low/Intermediate-1):
- Focus on supportive care and quality of life
- Transfuse RBCs to maintain Hb ≥8 g/dL (9-10 g/dL with comorbidities) 5
- Consider erythropoiesis-stimulating agents (ESAs) for anemia 5
- Monitor for iron overload if receiving >20-60 RBC units 5
Higher-risk MDS (IPSS Intermediate-2/High):
- Azacitidine improves survival 5
- Allogeneic stem cell transplant for select fit patients
- However, at age 80 with severe pancytopenia, transplant is rarely appropriate 6
Immediate Management Priorities
While completing workup:
- Transfuse RBCs if symptomatic or Hb <7-8 g/dL
- Avoid prophylactic platelet transfusions unless active bleeding or invasive procedure planned 5
- Start broad-spectrum antibiotics immediately if fever develops 5
- Do NOT use prophylactic antibiotics or G-CSF for neutropenia unless receiving myelosuppressive therapy 5
Age-Specific Considerations
At 80 years old, treatment decisions must prioritize quality of life over aggressive interventions 6:
- Elderly patients have inferior outcomes with intensive immunosuppression 6
- Comorbidities significantly impact treatment tolerance
- Supportive care alone may be most appropriate if patient is frail 5
- Individual patient wishes must be respected 6
Multifactorial Anemia Possibility
Remember that 11.4% of elderly anemic patients have combined renal insufficiency, inflammation, and functional iron deficiency 3. Even with MDS diagnosis, addressing concurrent treatable factors improves outcomes.